Related references
Note: Only part of the references are listed.Cellular therapy to control tumor progression
Markus Kapp et al.
CURRENT OPINION IN HEMATOLOGY (2009)
Feridex preloading permits tracking of CNS-resident macrophages after transient middle cerebral artery occlusion
Erica C. Henning et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin αvβ3-rich tumor cells
Jin Xie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Controlled etching of carbon nanotubes by iron-catalyzed steam gasification
Wei Xia et al.
ADVANCED MATERIALS (2007)
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
N Desai et al.
CLINICAL CANCER RESEARCH (2006)
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
J Condeelis et al.
CELL (2006)
Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats
H Zhao et al.
JOURNAL OF NEUROSCIENCE (2005)
MRI detection of macrophage activity after new experimental stroke in rate: New indicators for late appearance of vascular degradation?
R Weber et al.
MAGNETIC RESONANCE IN MEDICINE (2005)
Iron oxide MR contrast agents for molecular and cellular imaging
JWM Bulte et al.
NMR IN BIOMEDICINE (2004)
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
C Murdoch et al.
BLOOD (2004)
Macrophage endocytosis of superparamagnetic iron oxide nanoparticles - Mechanisms and comparison of Ferumoxides and Ferumoxtran-10
I Raynal et al.
INVESTIGATIVE RADIOLOGY (2004)
Targeting of hematopoietic progenitor cells with MR contrast agents
HE Daldrup-Link et al.
RADIOLOGY (2003)
Share Paper
